Products and Resources Catalog

Fact sheet that provides an overview of the latest research supporting the effectiveness of the FDA-approved medications for treatment of opioid use disorders.

Fact sheet on how to respond to concerns about diversion of medications prescribed for treating opioid use disorders.

This is a one-page flyer detailing the objectives, mission and contact information of the South Africa HIV ATTC.

Treatment Strategies for Prescription Opioid Dependence is a package of tools and training resources for substance use disorders treatment providers. The results of the study have implications for the treatment of adults dependent on prescription opioids. The POATS Blending Team (BT) package is designed to help treatment providers incorporate study findings and recommendations into their practice.          

The Buprenorphine Treatment for Young Adults Blending Team designed a training package which highlights the findings of the NIDA CTN study that compared longer term versus short-term buprenorphine/naloxone treatment in an outpatient setting. The 3-hour training program examines the prevalence of and treatment admission rates for nonmedical use of opioids among young adults; provides an overview of opioid use among young adults; explores and increases understanding of the results of new research on using buprenorphine to treat opioid addiction in young adults; and describes the implications of these findings for the treatment of opioid addiction in young adults.        

Motivational Incentives-A Proven Approach to Treatment is a collection of products which offer tools needed to learn about and use Motivational Incentives. Also, referred to as Contingency Management, Motivational Incentives has been subject to decades of research in the addiction treatment field; beginning in the 1960s. This collection of products assists organizations along a continuum from raising awareness about Motivational Incentives through dissemination and implementation activities.   What will you find at BetterTxOutcomes.org? Promoting Awareness of Motivational Incentives (PAMI) is an introductory training that exposes organizations to the principles of Motivational Incentives and demonstrates evidence of clinical effectiveness. Behavioral healthcare practitioners can then deepen their knowledge about Motivational Incentives through participating in the free, self-guided, interactive on-line course, Motivational Incentives: Positive Reinforcers to Enhance Successful Treatment Outcomes (MI:PRESTO).      

The Short-term Opioid Withdawal Using Buprenorphine (Bup Detox) Blending Team designed a training package to instruct treatment providers on the administration of aBup Detox Brochure Cover unique,13-day Buprenorphine taper intervention for opioid dependent patients. Research conducted in both inpatient and outpatient settings by the NIDA Clinical Trials Network demonstrated that, in contrast with the clonidine treatment group, patients receiving Buprenorphine provided more opioid-negative urine samples upon completion of the intervention. This training assumes some basic prior information about what Buprenorphine is and how it is used.            

Two-page fact sheet with facts about Marijuana and its use as well as its effects on the body, tips for cutting back, and helpful links.

This 8-hour self-paced course is based on the transdisciplinary foundations of the Substance Abuse and Mental Health Services Administration's Technical Assistance Publication #21, Addiction Counseling Competencies. Designed to provide an overview of the addictive process and basic knowledge, attitudes, and skills utilized by professionals from a variety of backgrounds who work with clients experiencing substance use disorders.

This presentation had four objective. (1) Detail the scope of the problem. (2) Describe why adolescence is a key period in the pathogenesis of addiction. (3) Explain the prevalence and clinical importance of co-occurring disorders. (4) Review evidence-based interventions & recommendations for improving treatment. Presented by Robert Miranda, Ph.D.

Self-paced course designed to enhance professional knowledge of MAT and build skills for educating patients about MAT.

This multidisciplinary six-module training series provides information about the use of medication-assisted treatment for opioid use disorders.

This presentation discussed trauma-informed approaches to the assessment and treatment of adolescent substance use. Presented by Kay Jankowski, Ph.D.

Dr. Thomas E. Freese, Director of the Pacific Southwest ATTC, explains what is meant by "medical" marijuana, who uses it and why, and the difference between medical marijuana and FDA approved medications.

Q&A with marijuana expert Dr. Kevin Hill. Topics include Addiction/dependency, adolescence, effects on the body, medical marijuana, potency, and withdrawal.

Dr. Laura Borgelt, Professor at the University of Colorado Skaggs School of Pharmacy, discusses the effects marijuana use can have on women who are pregnant, breastfeeding, the unborn child, and newborns.

This presentation discussed challenges and opportunities working with adolescents with substance use disorders, with a focus on continuity of care. Presented by Yifrah Kaminer, M.D.

Dr. Kari Franson from the University of Colorado's Skaggs School of Pharmacy and Pharmaceutical Sciences shares information on the long-term negative outcomes marijuana use has on developing adolescents.

Dr. Wilson M. Compton, Deputy Director at NIDA, highlights the adverse effects of marijuana use can have on the brain, heart, and respiratory. The video also provides some information on second hand exposure and current marijuana potency.

Eight, 1-page color infographics (Four in English, four in Spanish) covering 1) Effects on the body 2) Use and educational outcomes, 3) Effects on pregnancy and newborns, and 4) Medical use.

Dr. Yifrah Kaminer from the University of Connecticut Health gives an overview of the latest research on the marijuana's effects on the brain and how legalization affects states' SUD treatment and prevention systems.

This training presentation provides information about the use of Buprenorphine in medication-assisted treatment for opioid use disorders.

The purpose of this half-day, introductory training is to provide HIV clinicians (including, but not limited to physicians, dentists, nurses, and other allied medical staff, therapists and social workers, and counselors, specialists, and case managers) with an overview of medical marijuana, its use among individuals living with HIV, and strategies on how to work with HIV patients who are using medical marijuana.

This book comprises 20 essays in which family members described, in their own words, the most challenging part about having a family member with a substance use disorder, what it means to have a loved one find long-term recovery and explain why they are committed to recovery.